{"id":11322,"date":"2022-07-01T20:32:33","date_gmt":"2022-07-02T00:32:33","guid":{"rendered":"https:\/\/www.cancerresearch.org\/event\/developing-effective-immunotherapy-for-ovarian-cancer-and-other-tumors\/"},"modified":"2022-07-14T15:55:53","modified_gmt":"2022-07-14T19:55:53","slug":"developing-effective-immunotherapy-ovarian-cancer","status":"publish","type":"cri_events","link":"https:\/\/www.cancerresearch.org\/es\/events\/developing-effective-immunotherapy-ovarian-cancer","title":{"rendered":"Developing Effective Immunotherapy for Ovarian Cancer and Other Tumors"},"content":{"rendered":"<p style=\"text-align:center\"><iframe loading=\"lazy\" allowfullscreen=\"\" frameborder=\"0\" height=\"360\" src=\"https:\/\/www.youtube.com\/embed\/gxHPCxPyem8\" width=\"640\"><\/iframe><\/p>\n<p>On June 17, 2014, George Coukos, MD, PhD, director of the department of oncology at the CHUV, director of the service of developmental therapeutics, and the director of the Ludwig Centre at Lausanne, discussed how current immunotherapy treatment options for women with gynecologic cancers, and how close we are to making these treatments available to more patients.<\/p>\n<p>Prior to his current roles, Dr. Coukos was the Celso Ramon Garcia Professor and Associate Chief of the Division of Gynecologic Oncology, and Director, Ovarian Cancer Research Center, at the University of Pennsylvania Abramson Cancer Center. He is a recognized global leader in ovarian cancer immunotherapy and tumor microenvironment research. His research focuses on understanding the immune system&#39;s response to ovarian cancer and other tumor types, and on developing therapies that enhance that response. He is also developing tools to target the tumor vasculature. Dr. Coukos also has extensive experience in designing and conducting phase I clinical cell-based immunotherapy studies, and in the development of cell-based immunotherapy from the laboratory to the clinic.<\/p>\n<p>This webinar is part of the Cancer Research Institute&#39;s webinar series, &quot;Cancer Immunotherapy and You,&quot; which are offered free to the public and feature informative updates for patients and caregivers from leaders in cancer immunotherapy, followed by a Q&amp;A. This webinar was generously supported by Agenus. For more information on this webinar, or to register for upcoming webinars, please visit <a href=\"https:\/\/www.cancerresearch.org\/webinars\" target=\"_blank\" rel=\"noopener\">www.cancerresearch.org\/webinars<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dr. George Coukos of&nbsp;the University of Pennsylvania discusses current immunotherapy treatment options for women with gynecologic cancers, and how close we are to making these treatments available to more patients.<\/p>\n","protected":false},"featured_media":467,"template":"","events_categories":[198],"resource_cancer_types":[],"resource_patient_age":[],"resource_cancer_stage":[],"resource_treatment_type":[],"resource_treatment_status":[],"class_list":["post-11322","cri_events","type-cri_events","status-publish","has-post-thumbnail","hentry","events_categories-webinars"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Developing Effective Immunotherapy for Ovarian Cancer<\/title>\n<meta name=\"description\" content=\"Dr. George Coukos of\u00a0the University of Pennsylvania discusses current immunotherapy treatment options for women with gynecologic cancers.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cancerresearch.org\/events\/developing-effective-immunotherapy-ovarian-cancer\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Developing Effective Immunotherapy for Ovarian Cancer\" \/>\n<meta property=\"og:description\" content=\"Dr. George Coukos of\u00a0the University of Pennsylvania discusses current immunotherapy treatment options for women with gynecologic cancers.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cancerresearch.org\/events\/developing-effective-immunotherapy-ovarian-cancer\" \/>\n<meta property=\"og:site_name\" content=\"Cancer Research Institute\" \/>\n<meta property=\"article:modified_time\" content=\"2022-07-14T19:55:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/855f0078-9cb9-4af7-b3a8-55e0fd2167ba.jpg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Developing Effective Immunotherapy for Ovarian Cancer\" \/>\n<meta name=\"twitter:description\" content=\"Dr. George Coukos of\u00a0the University of Pennsylvania discusses current immunotherapy treatment options for women with gynecologic cancers.\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/855f0078-9cb9-4af7-b3a8-55e0fd2167ba.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/developing-effective-immunotherapy-ovarian-cancer\",\"url\":\"https:\/\/www.cancerresearch.org\/events\/developing-effective-immunotherapy-ovarian-cancer\",\"name\":\"Developing Effective Immunotherapy for Ovarian Cancer\",\"isPartOf\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/developing-effective-immunotherapy-ovarian-cancer#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/developing-effective-immunotherapy-ovarian-cancer#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/3ac3e649-af4e-457d-9b95-9745a513e33a.jpg\",\"datePublished\":\"2022-07-02T00:32:33+00:00\",\"dateModified\":\"2022-07-14T19:55:53+00:00\",\"description\":\"Dr. George Coukos of\u00a0the University of Pennsylvania discusses current immunotherapy treatment options for women with gynecologic cancers.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/developing-effective-immunotherapy-ovarian-cancer#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cancerresearch.org\/events\/developing-effective-immunotherapy-ovarian-cancer\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/developing-effective-immunotherapy-ovarian-cancer#primaryimage\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/3ac3e649-af4e-457d-9b95-9745a513e33a.jpg\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/3ac3e649-af4e-457d-9b95-9745a513e33a.jpg\",\"width\":320,\"height\":208},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/developing-effective-immunotherapy-ovarian-cancer#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.cancerresearch.org\/es\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Event\",\"item\":\"https:\/\/www.cancerresearch.org\/events\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Developing Effective Immunotherapy for Ovarian Cancer and Other Tumors\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cancerresearch.org\/#website\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"name\":\"Cancer Research Institute\",\"description\":\"For a World Immune to Cancer\",\"publisher\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cancerresearch.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\",\"name\":\"Cancer Research Institute\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"width\":156,\"height\":53,\"caption\":\"Cancer Research Institute\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Developing Effective Immunotherapy for Ovarian Cancer","description":"Dr. George Coukos of\u00a0the University of Pennsylvania discusses current immunotherapy treatment options for women with gynecologic cancers.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cancerresearch.org\/events\/developing-effective-immunotherapy-ovarian-cancer","og_locale":"es_ES","og_type":"article","og_title":"Developing Effective Immunotherapy for Ovarian Cancer","og_description":"Dr. George Coukos of\u00a0the University of Pennsylvania discusses current immunotherapy treatment options for women with gynecologic cancers.","og_url":"https:\/\/www.cancerresearch.org\/events\/developing-effective-immunotherapy-ovarian-cancer","og_site_name":"Cancer Research Institute","article_modified_time":"2022-07-14T19:55:53+00:00","og_image":[{"url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/855f0078-9cb9-4af7-b3a8-55e0fd2167ba.jpg","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_title":"Developing Effective Immunotherapy for Ovarian Cancer","twitter_description":"Dr. George Coukos of\u00a0the University of Pennsylvania discusses current immunotherapy treatment options for women with gynecologic cancers.","twitter_image":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/855f0078-9cb9-4af7-b3a8-55e0fd2167ba.jpg","twitter_misc":{"Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.cancerresearch.org\/events\/developing-effective-immunotherapy-ovarian-cancer","url":"https:\/\/www.cancerresearch.org\/events\/developing-effective-immunotherapy-ovarian-cancer","name":"Developing Effective Immunotherapy for Ovarian Cancer","isPartOf":{"@id":"https:\/\/www.cancerresearch.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cancerresearch.org\/events\/developing-effective-immunotherapy-ovarian-cancer#primaryimage"},"image":{"@id":"https:\/\/www.cancerresearch.org\/events\/developing-effective-immunotherapy-ovarian-cancer#primaryimage"},"thumbnailUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/3ac3e649-af4e-457d-9b95-9745a513e33a.jpg","datePublished":"2022-07-02T00:32:33+00:00","dateModified":"2022-07-14T19:55:53+00:00","description":"Dr. George Coukos of\u00a0the University of Pennsylvania discusses current immunotherapy treatment options for women with gynecologic cancers.","breadcrumb":{"@id":"https:\/\/www.cancerresearch.org\/events\/developing-effective-immunotherapy-ovarian-cancer#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cancerresearch.org\/events\/developing-effective-immunotherapy-ovarian-cancer"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/events\/developing-effective-immunotherapy-ovarian-cancer#primaryimage","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/3ac3e649-af4e-457d-9b95-9745a513e33a.jpg","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/3ac3e649-af4e-457d-9b95-9745a513e33a.jpg","width":320,"height":208},{"@type":"BreadcrumbList","@id":"https:\/\/www.cancerresearch.org\/events\/developing-effective-immunotherapy-ovarian-cancer#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cancerresearch.org\/es"},{"@type":"ListItem","position":2,"name":"Event","item":"https:\/\/www.cancerresearch.org\/events"},{"@type":"ListItem","position":3,"name":"Developing Effective Immunotherapy for Ovarian Cancer and Other Tumors"}]},{"@type":"WebSite","@id":"https:\/\/www.cancerresearch.org\/#website","url":"https:\/\/www.cancerresearch.org\/","name":"Cancer Research Institute","description":"For a World Immune to Cancer","publisher":{"@id":"https:\/\/www.cancerresearch.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cancerresearch.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cancerresearch.org\/#organization","name":"Cancer Research Institute","url":"https:\/\/www.cancerresearch.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","width":156,"height":53,"caption":"Cancer Research Institute"},"image":{"@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_events\/11322","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_events"}],"about":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/types\/cri_events"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media\/467"}],"wp:attachment":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media?parent=11322"}],"wp:term":[{"taxonomy":"events_categories","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/events_categories?post=11322"},{"taxonomy":"resource_cancer_types","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_cancer_types?post=11322"},{"taxonomy":"resource_patient_age","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_patient_age?post=11322"},{"taxonomy":"resource_cancer_stage","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_cancer_stage?post=11322"},{"taxonomy":"resource_treatment_type","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_treatment_type?post=11322"},{"taxonomy":"resource_treatment_status","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_treatment_status?post=11322"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}